Ecnoglutide
Ecnoglutide, a long-acting biased GLP-1 receptor agonist
N/A Amino Acids · MW: N/A
Amino Acids
N/A
Molecular Weight
N/A
Half-life
approximately 5-7 days
Research Score
4.4
Studies
8
Storage
Store lyophilized at -20°C, reconstituted at 2-8°C
What is Ecnoglutide?
Ecnoglutide is a long-acting GLP-1 analogue designed with biased receptor signaling and improved pharmacokinetics. It is being studied for type 2 diabetes and obesity, with early work suggesting strong efficacy and once-weekly convenience.
Key Benefits & Mechanisms
glycemic improvement
weight loss
once-weekly dosing
biased signaling profile
Research Summary
Published studies and trial reports indicate ecnoglutide can lower HbA1c and body weight in patients with metabolic disease. Research interest remains high because its biased signaling may translate into a favorable efficacy-to-tolerability balance.
Related Peptides
RgIA
alpha-Conotoxin RgIA from Conus regius venom
RgIA is a disulfide-rich cone snail peptide that selectively antagonizes the alpha9alpha10 nicotinic acetylcholine receptor. It is used as a research tool in pain and neuroimmune signaling studies and as a pre-clinical analgesic lead.
ExperimentalConantokin-G
Conantokin-G from Conus geographus venom
Conantokin-G is a gamma-carboxyglutamate-rich cone snail peptide that antagonizes NMDA receptor activity. It has been used extensively to study excitatory neurotransmission and seizure biology.
ExperimentalMambalgin-1
Mambalgin-1 from Dendroaspis polylepis venom
Mambalgin-1 is a three-finger snake venom peptide that inhibits acid-sensing ion channels (ASICs), especially ASIC1a and ASIC1b. It is studied as a non-opioid analgesic lead with strong mechanistic value in sensory neuroscience.
ExperimentalHuwentoxin-IV
Huwentoxin-IV from Selenocosmia huwena venom
Huwentoxin-IV is a spider venom peptide that potently targets voltage-gated sodium channels, with strong interest around Nav1.7. It is widely used as a tool compound for ion-channel pharmacology and analgesic discovery.
Experimental